Jeremy Grantham Viatris Inc Call Options Transaction History
Grantham, Mayo, Van Otterloo & Co. LLC
- $31.8 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VTRS
# of Institutions
1,127Shares Held
987MCall Options Held
7.62MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA145MShares$1.53 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$979 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD78.8MShares$832 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az66.4MShares$701 Million3.26% of portfolio
-
State Street Corp Boston, MA55.3MShares$584 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $12.8B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...